Active Ingredient: RANOLAZINE
Proprietary Name: RANOLAZINE
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 500MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A213085
Product Number: 001
Approval Date: Jul 25, 2023
Applicant Holder Full Name: PIRAMAL HEALTHCARE UK LTD
Marketing Status:
Discontinued
Patent and Exclusivity Information